MET Human shRNA Plasmid Kit (Locus ID 4233)

SKU
TG320418
MET - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
  $883.00
In Stock*
Specifications
Specifications
Product Data
Locus ID 4233
Synonyms AUTS9; c-Met; DFNB97; HGFR; RCCP2
Vector pGFP-V-RS
E. coli Selection Kanamycin
Mammalian Cell Selection Puromycin
Format Retroviral plasmids
Components MET - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 4233). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.
RefSeq NM_000245, NM_001127500, NM_001324401, NM_001324402, NM_000245.1, NM_000245.2, NM_000245.3, NM_001127500.1, NM_001127500.2, BC016592, BC027979, BC127890, BC130420, NM_001127500.3, NM_000245.4
UniProt ID P08581
Summary This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers. provided by RefSeq, May 2016
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
Park, Choi, Ko et al
Cancer Res Treat (2017)
AI Summary: OriGene’s pGFP-V-RS plasmid vectors containing MET shRNA were used in this study to stably silence MET expression, enabling the authors to investigate the role of MET in acquired lapatinib resistance in HER2-positive gastric cancer cells.
Snippet: 9. MET silencing by stable transfection with shRNA plasmid vector For MET silencing, the pGFP-V-RS plasmid vectors containing either scrambled shRNA or MET shRNA were purchased from OriGene (Rockville, MD, USA). The sequence of MET ... Cite SaveSaving
The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
Steinway, Dang, You et al
PLoS One (2015) 10 (5), e0128159 DOI: 10.1371/journal.pone.0128159
Cited by 36
AI Summary: In this study, OriGene’s c-Met shRNA vector was used to generate stable c-Met knockdown MHCC97-H hepatocellular carcinoma cells, enabling the researchers to investigate compensatory survival mechanisms following c-Met inhibition.
FigureFigureFigure
Induction of tumor initiation is dependent on CD44s in c-Met(+) hepatocellular carcinoma
Dang, Steinway, Ding et al
BMC Cancer (2015) 15, 161 DOI: 10.1186/s12885-015-1166-4
Cited by 27
AI Summary: OriGene’s TG320418 HuSH 29mer shRNA constructs against c-Met in the pGFP-V-RS vector were used to stably knock down c-Met expression in hepatocellular carcinoma cells, enabling the study of c-Met’s role in regulating CD44s expression and tumor-initiating properties.
Snippet: c-Met siRNA was acquired from Thermo Scientific (Dharmacon, Chicago, IL). Stable shRNA: TG320418 HuSH 29mer shRNA constructs against c-Met in the pGFP-V-RS vector was purchase from OriGene (Rockville, MD). The ... Cite SaveSaving
FigureFigureFigure
Induction of tumor initiation is dependent on CD44s in c-Met+ hepatocellular carcinoma
Dang, Steinway, Ding et al
BMC Cancer (2015) 15 (161)
AI Summary: OriGene contributed to the study by providing the TG320418 HuSH 29mer shRNA constructs against c-Met in the pGFP-V-RS vector, which were used for stable gene silencing experiments.
Snippet: c-Met siRNA was acquired from Thermo Scientific (Dharmacon, Chicago, IL). Stable shRNA: TG320418 HuSH 29mer shRNA constructs against c-Met in the pGFP-V-RS vector was purchase from OriGene (Rockville, MD). The ... Cite SaveSaving
Showing 1-4 of 4 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products